Wan Mui Chan
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 3
- Epigenetics and DNA Methylation 3
- Ubiquitin and proteasome pathways 2
- RNA modifications and cancer 1
- Oncology 6
- Cancer-related Molecular Pathways 6
- Co-authors
- Randy Y.C. Poon (6 shared papers)Wai Yi Siu (4 shared papers)Anita Lau (4 shared papers)Vincent Chi‐Chung Cheng (2 shared papers)Bosco Lam (2 shared papers)Ivan Fan Ngai Hung (2 shared papers)Jonathan Daniel Ip (2 shared papers)Jacky Man Chun Chan (2 shared papers)
In The Last Decade
Wan Mui Chan
8 papers receiving 575 citations
Wan Mui Chan's Hit Papers
Peers
Comparison fields: 5 of 69
- Infectious Diseases 246
- Oncology 199
- Biotechnology 42
- Molecular Biology 278
- Modeling and Simulation 18
Countries citing papers authored by Wan Mui Chan
This map shows the geographic impact of Wan Mui Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Mui Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Mui Chan more than expected).
Fields of papers citing papers by Wan Mui Chan
This network shows the impact of papers produced by Wan Mui Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Mui Chan. The network helps show where Wan Mui Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wan Mui Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients Hit paper breakdown → | 2021 | 238 |
| 2 | 2004 | 134 | |
| 3 | 2006 | 55 | |
| 4 | 2022 | 51 | |
| 5 | 2003 | 42 | |
| 6 | 2006 | 31 | |
| 7 | 2008 | 19 | |
| 8 | 2007 | 11 |
About Wan Mui Chan
Wan Mui Chan is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Cell Biology and Biotechnology, having authored 8 papers that have together received 581 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), DNA Repair Mechanisms (3 papers), Epigenetics and DNA Methylation (3 papers), Ubiquitin and proteasome pathways (2 papers), Microtubule and mitosis dynamics (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Cancer Research and Treatments (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Infectious Diseases (246 citations), Oncology (199 citations), Biotechnology (42 citations), Molecular Biology (278 citations) and Modeling and Simulation (18 citations). Wan Mui Chan has collaborated with scholars based in Hong Kong, China and Japan. Frequent co-authors include Randy Y.C. Poon, Wai Yi Siu, Anita Lau, Vincent Chi‐Chung Cheng, Bosco Lam, Ivan Fan Ngai Hung, Jonathan Daniel Ip, Jacky Man Chun Chan, Kwok Yung Yuen and Kelvin Kai Wang To. Their work appears in journals such as Clinical Infectious Diseases, Cancer Research, Molecular Biology of the Cell, Journal of Biological Chemistry and Molecular Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.